Erdélyi, László Sándor <br/><br/>
Altered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus.  [electronic resource] 

 -  Molecular endocrinology (Baltimore, Md.)  May 2014 
 - 634-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1944-9917 
<br/><br/><label>Standard No.: </label>10.1210/me.2013-1424  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Antidiuretic Agents--pharmacology<br/>Cyclic AMP--metabolism<br/>DNA Mutational Analysis<br/>Deamino Arginine Vasopressin--pharmacology<br/>Diabetes Insipidus, Nephrogenic--drug therapy<br/>Endoplasmic Reticulum<br/>HEK293 Cells<br/>Humans<br/>In Vitro Techniques<br/>Male<br/>Mice<br/>Mutation, Missense<br/>Neurophysins--pharmacology<br/>Protein Precursors--pharmacology<br/>Rats<br/>Receptors, Vasopressin--agonists<br/>Second Messenger Systems<br/>Vasopressins--pharmacology